![Efficacy and safety of anagrelide as a first‐line drug in cytoreductive treatment‐naïve essential thrombocythemia patients in a real‐world setting]()
Efficacy and safety of anagrelide as a first‐line drug in cytoreductive treatment‐naïve essential thrombocythemia patients in a real‐world settingIto, Tomoki; Hashimoto, Yoshinori; Tanaka, Yasuhiro; Nakaya, Aya; Fujita, Shinya; Satake, Atsushi; Nakanishi, Takahisa; Konishi, Akiko; Hotta, Masaaki; Yoshimura, Hideaki; Ishii, Kazuyoshi; Hashimoto, Akiko; Kondo, Toshinori; Omura, Hiromi; Shinzato, Isaku; Tanaka, Takayuki; Nomura, Shosaku · European Journal of Haematology · 2019